Detalhe da pesquisa
1.
Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures.
J Pharmacokinet Pharmacodyn
; 45(4): 649-658, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948795
2.
Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects.
J Pharmacol Exp Ther
; 345(1): 41-51, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23370795
3.
Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine.
Neuroimage
; 59(4): 3762-73, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22119647
4.
An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and Active Metabolite Desisobutyryl-Ciclesonide in Human Serum and Its Application to a Clinical Study.
J Appl Lab Med
; 5(1): 41-53, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31662413
5.
Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation.
Eur J Pharmacol
; 597(1-3): 39-45, 2008 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-18789923
6.
Population Pharmacokinetic Evaluation and Missed-Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial-Onset Seizures.
Clin Pharmacol Drug Dev
; 7(3): 287-297, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881418
7.
Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
J Clin Pharmacol
; 58(7): 927-938, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29528499
8.
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use.
Clin Pharmacol Ther
; 103(3): 378-383, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330855
9.
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Eur J Pharmacol
; 563(1-3): 92-101, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17349996
10.
Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters.
Epilepsy Res
; 135: 64-70, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624574
11.
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy.
Clin Pharmacol
; 9: 65-72, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28721105
12.
A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 5(4): 278-84, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27249205
13.
Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
Clin Drug Investig
; 36(2): 137-46, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26597180